CN102258645A

CN102258645A - Medicine for treating bronchial asthma

Info

Publication number: CN102258645A
Application number: CN2011102038118A
Authority: CN
Inventors: 杨万明
Original assignee: Individual
Current assignee: Individual
Priority date: 2011-07-21
Filing date: 2011-07-21
Publication date: 2011-11-30

Abstract

The invention relates to a medicine for treating bronchial asthma, which is prepared by the following steps: decocting herba ephedrae, toasted almond, mulberry bark, lumbricus, cicada shell, centipede, angelica, plantain, asarum, panicled swallowwort root, blackberrylily rhizome and raw licorice root in water, concentrating, adding conventional auxiliary materials, adding purified water until the content of crude drugs reaches 1g/ml, potting, and sterilizing to obtain an oral liquid preparation. The medicine for treating bronchial asthma can promote the dispersing function of the lung, relieve asthma, relieve spasm and remove anaphylaxis. The clinical observation proves that the effective rate of the medicine for treating bronchial asthma is 100%. The medicine for treating bronchial asthma is natural, pure, safe and innoxious, and people taking the medicine do not have dependence.

Description

A kind of medicine for the treatment of bronchial asthma

Technical field

The present invention relates to a kind of medicine for the treatment of bronchial asthma, particularly a kind of is the Chinese medicine of the treatment bronchial asthma of crude drug preparation with Chinese medicine.

Background technology

Asthma is universally acknowledged difficult medical problem, is classified as one of four big pertinacious diseases in the disease by World Health Organization (WHO).Bronchial asthma is that an a kind of bronchial reactivity that causes because of anaphylactogen or other factors increases, cause bronchial muscular spasm, mucosa swelling secretions increases, and the bronchial tube shin is narrow to be caused, ictal dyspnea and wheezing respiratory murmur are the disease of feature.This kind inflammation can cause repeatedly symptoms such as the panting of outbreak, tachypnea, uncomfortable in chest and cough in the susceptible person, how to take place at night or morning; This type of symptom is often limited with extensive and changeable exhalation flow rate.

On THE TREATMENT OF BRONCHIAL ASTHMA, be to adopt western medicine mostly at present.As the adrenomimetic drug medicine, comprise ephedrine, epinephrine, isoproterenol etc.Western medical treatment can only control of seizures, relief of symptoms, recurrence easily.Western medicine has certain side effect, and the life-time service hormone has untoward reaction to health.Especially at present Tri-Biocin is used in promotion less.

Summary of the invention

The purpose of this invention is to provide a kind of Chinese medicine for the treatment of bronchial asthma, the present invention's energy depressed lung-energy dispersing, spasmolytic desensitization.Natural pure, the safety non-toxic of this medicine does not have dependency.

Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:

Herba Ephedrae 6-9 stir-baked SEMEN ARMENIACAE AMARUM 12 Cortex Mori 18-25

Pheretima 10-15 Periostracum Cicadae 4-7 Scolopendra 5-6

Radix Angelicae Sinensis 10-15 Herba Plantaginis 18-25 Herba Asari 4-6

Radix Cynanchi Paniculati 18-25 Rhizoma Belamcandae 6-9 Radix Glycyrrhizae 5-8.

Said medicine can be made on the pharmaceutics any dosage form such as tablet, pill, powder, capsule, the present invention is oral liquid preferably.

The concrete preparation method of above-mentioned each component being made oral liquid of the present invention is:

With above-mentioned medicaments in part by weight mix homogeneously, decoct with water 2～4 times, each 1～2 hour, collecting decoction, filter, filtrate is condensed into the clear paste of 70 ℃ of relative densities 1.15～1.18, and cold preservation is left standstill, and gets supernatant and filters, add conventional adjuvant in the filtrate, mixing, adding purified water is 1g/ml to containing the crude drug amount, oral liquid formulations is made in embedding, sterilization.

Using method: oral, each 1 bag, every bag of 500ml, every day three times.

The traditional Chinese medical science think bronchial asthma many with suffer from a deficiency of the kidney, mental disorder, noxious dampness be relevant.The present invention is a good recipe of specially controlling bronchial asthma.We's epheday intermedia depressed lung-energy dispersing, the tonneau water channel; The Pheretima removing heat from blood is relievingd asthma, calming wind and dredging collateral; Herba Ephedrae is joined the Pheretima cold and heat and subtracts mutually, and negative and positive disappear mutually; Radix Cynanchi Paniculati, Periostracum Cicadae analgesia cough-relieving, dispelling wind and heat pathogens, spasmolytic desensitization; The clear eliminating the pathogens from the lung gas of Cortex Mori, Herba Asari eliminating cold for resuscitation air flue, two medicine simultaneously using both cold and hot drugs bring out the best in each other; The Herba Plantaginis diuresis is eliminated the phlegm, and the Cortex Mori coordinating effect is joined in the diuresis of relievining asthma; Because of prolonged illness must the stasis of blood, thus can blood circulation promoting and blood stasis dispelling with Radix Angelicae Sinensis, the sharp lung network that looses; Scolopendra has the spasmolytic of relieving dizziness, high fever, infantile convulsions, epilepsy, etc., detoxicating and resolving stagnation of pathogens, and the active eliminating stagnation of Radix Angelicae Sinensis, and Scolopendra is joined Pheretima and can remove bronchospasm, relieving asthma.Add Bombyx Batryticatus, Herba Houttuyniae, Cortex Lycii as disease type partial heat; Cold partially Herba Asari dosage adds Rhizoma Zingiberis again, and the abundant expectoration QI rising in reverse order adds booth Li, the Rhizoma Pinelliae, Poria, coughs play and adds Flos Farfarae, processs Folium Eriobotryae, processs Radix Asteris, and the deficiency of vital energy adds the Radix Astragali, Radix Pseudostellariae, suffers from a deficiency of the kidney to add Fructus Psoraleae, semen juglandis etc.

More than all medicines share, be used for the treatment of bronchial asthma cure rate height, no Western medicine preparation is to side effect such as human internal organ infringements, also drug resistance such as antibiotic-free.

For further investigating the clinical efficacy and the safety of medicine of the present invention, select 7 routine bronchial asthma patients that the curative effect of medicine of the present invention is carried out clinical observation.

Criterion of therapeutical effect: according to the clinical research guideline of bronchial asthma " new Chinese medicine treatment " regulation, efficacy determination is based on transference cure, and with reference to change situations such as signs, is divided into healing, produce effects, effective, invalid level Four.Cure: symptom and sign all disappear.Produce effects: symptom and sign are obviously improved.Effectively: symptom and sign have certain improvement.Invalid: symptom and sign all do not have improvement.

Observe patient's logotype ten days through treatment.7 routine patients cure 6 examples, produce effects 1 example, total effective rate 100%.Without any side effect and untoward reaction.

The specific embodiment

Embodiment:

Get Herba Ephedrae 9g, stir-baked SEMEN ARMENIACAE AMARUM 12g, Cortex Mori 20g, Pheretima 12g, Periostracum Cicadae 6g, Scolopendra 2-3 bar, Radix Angelicae Sinensis 12g, Herba Plantaginis 20g, Herba Asari 5g, Radix Cynanchi Paniculati 20g, Rhizoma Belamcandae 9g, Radix Glycyrrhizae 6g.Clean with clear water, decoct with water 3 times, each 1～2 hour, collecting decoction, filter, filtrate is condensed into the clear paste of 70 ℃ of relative densities 1.15～1.18, and cold preservation is left standstill, and gets supernatant and filters, add conventional adjuvant in the filtrate, mixing, adding purified water is 1g/ml to containing the crude drug amount, oral liquid formulations is made in embedding, sterilization.

Case history one: Lee, the man, 36 years old, to go to a doctor in June, 2009, asthma takes place suddenly spring before 2 years in the patient, and increase the weight of night, coughs white foam expectorant, half an hour persistent period, surplus in the of days ten time, once went examination in hospital diagnosis bronchial asthma, anaphylactogen is a pollen.Once gave remissions such as antiallergic, aerosol, outbreak of annual spring afterwards, the hot summer also shows effect recently, and symptom is heavier.Look into two lungs and be abound with the asthma sound, respiratory murmur subtracts sound, and pale tongue with white fur is greasy, stringy and rolling pulse and late.Relieving asthma after examining four doses of soup, patient's sx, expectorant are coughed less and are ended, tongue arteries and veins such as preceding gives we and adds Herba Asari, Rhizoma Zingiberis transference cure, give the giving young employees remedial-courses in general knowledge and vocational skills of lung kidney with kind thereafter.

Case history two: the Wang, the woman, 48 years old, first visit in April, 2011, the patient, takes a turn for the better behind anti-common cold treatment because of back heating, cough, expectoration, the asthma of catching a cold in the year before.But asthma, rhinorrhea, rhinocnesmus, ophthalmic pruritus sx are diagnosed as " bronchial asthma ", and the chemical examination anaphylactogen is " a dirt demodicid mite ", gives antiallergic, and aminophylline, ketone are for remission, recoveries such as powder.But bring out primary disease again with factors such as climate changes, the patient coughs white foam expectorant, and the Asthma Day at light night is heavy, and the enlarged tongue tongue is thick in vain.Give four doses of we.The flat expectorant of roaring disappears to cough and ends, and adds 2-3 for former side's amount and doubly grinds conditioning month surplus recovery from illness into powder.

Claims

1. medicine for the treatment of bronchial asthma is characterized in that:

Medicine of the present invention is that feedstock production obtains by following parts by weight of traditional Chinese medicines:

Herba Ephedrae 6-9 stir-baked SEMEN ARMENIACAE AMARUM 12 Cortex Mori 18-25

Pheretima 10-15 Periostracum Cicadae 4-7 Scolopendra 5-6

Radix Angelicae Sinensis 10-15 Herba Plantaginis 18-25 Herba Asari 4-6

Radix Cynanchi Paniculati 18-25 Rhizoma Belamcandae 6-9 Radix Glycyrrhizae 5-8.

2. the medicine of treatment bronchial asthma according to claim 1, its feature is being that described medicine is made oral liquid.

3. the preparation method of the medicine of the described treatment bronchial asthma of claim 2 is: with above-mentioned medicaments in part by weight mix homogeneously, decoct with water 2～4 times, each 1～2 hour, collecting decoction, filter, filtrate is condensed into the clear paste of 70 ℃ of relative densities 1.15～1.18, and cold preservation is left standstill, and gets supernatant and filters, add conventional adjuvant in the filtrate, mixing, adding purified water is 1g/ml to containing the crude drug amount, oral liquid formulations is made in embedding, sterilization.